LSL Pharma Group Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	-	0.3	0.01	-	0.74	1.93
Cash & Short-Term Investments	-	0.3	0.01	-	0.74	1.93
Cash Growth	-	3600.00%	-	-	-61.52%	316.66%
Accounts Receivable	-	4.8	2.55	0.97	1.12	2.22
Other Receivables	-	0.15	0.13	0.07	0.22	0.19
Receivables	-	4.96	2.68	1.04	1.33	2.4
Inventory	-	9.12	4.11	2.96	4.17	2.13
Prepaid Expenses	-	1.01	0.41	0.21	0.13	0.05
Other Current Assets	20.66	-	-	0.19	0.11	-
Total Current Assets	20.66	15.38	7.2	4.4	6.48	6.51
Property, Plant & Equipment	24.83	22.94	14.75	13.92	12.89	10.3
Goodwill	-	0.16	-	-	-	-
Other Intangible Assets	14.33	13.27	8.93	8.98	9.39	9.81
Long-Term Deferred Tax Assets	-	0.22	-	-	-	0.1
Other Long-Term Assets	0.38	1.54	0.02	0.02	0.28	0.46
Total Assets	60.19	53.51	30.9	27.31	29.03	27.18
Accounts Payable	-	4.5	4.92	4.54	2.54	2.47
Accrued Expenses	-	0.69	1.06	1.58	1.17	1.64
Short-Term Debt	6.34	2.56	3.77	2.91	-	-
Current Portion of Long-Term Debt	-	1.45	5.22	1.58	1.89	6.03
Current Portion of Leases	-	0.45	0.12	0.14	0.19	0.24
Current Unearned Revenue	-	-	-	0.01	-	0.51
Other Current Liabilities	7.2	-	-	0.87	1.46	1.66
Total Current Liabilities	13.54	9.65	15.07	11.62	7.25	12.55
Long-Term Debt	15.26	12.75	4.73	7.84	7.98	3.36
Long-Term Leases	-	4.43	2.44	2.56	2.69	0.94
Long-Term Deferred Tax Liabilities	-	1.79	-	-	-	-
Total Liabilities	34.81	28.62	22.25	22.02	17.92	16.84
Common Stock	25.38	36.39	24.2	15.05	12.81	10.26
Additional Paid-In Capital	-	3.05	2.32	-	-	-
Retained Earnings	-	-14.92	-18.23	-9.76	-1.7	0.08
Comprehensive Income & Other	-	0.38	0.38	-	-	-
Shareholders' Equity	25.38	24.89	8.66	5.29	11.11	10.34
Total Liabilities & Equity	60.19	53.51	30.9	27.31	29.03	27.18
Total Debt	21.6	21.64	16.27	15.03	12.74	10.57
Net Cash (Debt)	-21.6	-21.34	-16.26	-15.03	-12	-8.64
Net Cash Per Share	-0.19	-0.20	-0.20	-0.23	-0.20	-0.16
Filing Date Shares Outstanding	115.53	115.53	82.44	68.09	62.66	54.89
Total Common Shares Outstanding	115.53	115.53	82.44	68.09	62.66	54.89
Working Capital	7.12	5.72	-7.87	-7.22	-0.78	-6.04
Book Value Per Share	0.22	0.22	0.10	0.08	0.18	0.19
Tangible Book Value	11.05	11.46	-0.28	-3.69	1.72	0.54
Tangible Book Value Per Share	0.10	0.10	-0.00	-0.05	0.03	0.01
Land	-	0.56	0.28	0.28	0.28	0.28
Buildings	-	5.61	3.97	3.91	3.63	3.51
Machinery	-	11.41	6.02	5.55	5.33	4.73
Construction In Progress	-	-	-	1.77	0.47	-
Leasehold Improvements	-	3.99	3.71	0.93	0.93	0.82

Source: S&P Global Market Intelligence. Standard template. Financial Sources.